etigilimab,nivolumab
mereo pharmaceuticals,bms
['nivo', 'nivolumab', 'etigilimab']
#mereobiopharma to present data update for the phase 1b/2 study (#activate) of #etigilimab and #nivolumab at #asco22 $mreo 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.